112 related articles for article (PubMed ID: 8846250)
1. Decrease of optic disc cupping and pallor of ocular hypertensives with timolol therapy.
Schwartz B; Lavin P; Takamoto T; Araujo DF; Smits G
Acta Ophthalmol Scand Suppl; 1995; (215):5-21. PubMed ID: 8846250
[TBL] [Abstract][Full Text] [Related]
2. Increase of retinal vessel width in ocular hypertensives with timolol therapy.
Schwartz B; Takamoto T; Lavin P
Acta Ophthalmol Scand Suppl; 1995; (215):41-53. PubMed ID: 8846249
[TBL] [Abstract][Full Text] [Related]
3. Increase of retinal nerve fiber layer thickness in ocular hypertensives with timolol therapy.
Schwartz B; Takamoto T; Lavin P; Smits G
Acta Ophthalmol Scand Suppl; 1995; (215):22-32. PubMed ID: 8846247
[TBL] [Abstract][Full Text] [Related]
4. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.
Kass MA
Trans Am Ophthalmol Soc; 1989; 87():598-618. PubMed ID: 2562546
[TBL] [Abstract][Full Text] [Related]
5. Measurements of reversibility of optic disc cupping and pallor in ocular hypertension and glaucoma.
Schwartz B; Takamoto T; Nagin P
Ophthalmology; 1985 Oct; 92(10):1396-1407. PubMed ID: 4069603
[TBL] [Abstract][Full Text] [Related]
6. Reversibility by timolol of optic nerve disc cupping and pallor in ocular hypertensives.
Schwartz B
Surv Ophthalmol; 1989 Apr; 33 Suppl():419-20; discussion 421-2. PubMed ID: 2749510
[No Abstract] [Full Text] [Related]
7. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.
Kass MA; Gordon MO; Hoff MR; Parkinson JM; Kolker AE; Hart WM; Becker B
Arch Ophthalmol; 1989 Nov; 107(11):1590-8. PubMed ID: 2818278
[TBL] [Abstract][Full Text] [Related]
8. Increased preferential optic disc asymmetry in ocular hypertensive patients compared with control subjects.
Carassa RG; Schwartz B; Takamoto T
Ophthalmology; 1991 May; 98(5):681-91. PubMed ID: 2062502
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of timolol therapy in ocular hypertension: a double-masked, randomised trial.
Heijl A; Bengtsson B
Graefes Arch Clin Exp Ophthalmol; 2000 Nov; 238(11):877-83. PubMed ID: 11148810
[TBL] [Abstract][Full Text] [Related]
10. Diversity of response of optic nerve head circulation to timolol maleate in gel-forming solution.
Netland PA; Schwartz B; Feke GT; Takamoto T; Konno S; Goger DG
J Glaucoma; 1999 Jun; 8(3):164-71. PubMed ID: 10376255
[TBL] [Abstract][Full Text] [Related]
11. Association of ocular pressure and optic disc cup volume with red blood cell sodium-potassium ATPase inhibition.
Schwartz B; Abrahamson R; Takamoto T; Wysocki A
Curr Eye Res; 2000 Nov; 21(5):897-905. PubMed ID: 11262612
[TBL] [Abstract][Full Text] [Related]
12. [Pallor of the optic papilla--an early sign of glaucoma. A clinical controlled study of optic disk pallor and papillar cupping in glaucoma simplex, ocular hypertension and normal eyes with the optic nerve head analyzer].
Siebert M; Gramer E; Leydhecker W
Klin Monbl Augenheilkd; 1989 Jun; 194(6):433-6. PubMed ID: 2761191
[TBL] [Abstract][Full Text] [Related]
13. Increase of pallor and fluorescein-filling defects of the optic disc in the follow-up of ocular hypertensives measured by computerized image analysis.
Tuulonen A; Nagin P; Schwartz B; Wu DC
Ophthalmology; 1987 May; 94(5):558-63. PubMed ID: 3601372
[TBL] [Abstract][Full Text] [Related]
14. Changes in optic disc in ocular hypertension and glaucoma.
Schwartz B
Jpn J Ophthalmol; 1986; 30(2):143-53. PubMed ID: 3761738
[TBL] [Abstract][Full Text] [Related]
15. Optic disc changes in ocular hypertension.
Schwartz B
Surv Ophthalmol; 1980; 25(3):148-54. PubMed ID: 7466594
[TBL] [Abstract][Full Text] [Related]
16. Effect of dorzolamide and timolol on ocular pressure: blood flow relationship in patients with primary open-angle glaucoma and ocular hypertension.
Fuchsjäger-Mayrl G; Georgopoulos M; Hommer A; Weigert G; Pemp B; Vass C; Garhöfer G; Schmetterer L
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1289-96. PubMed ID: 19850848
[TBL] [Abstract][Full Text] [Related]
17. A comparison of treated and untreated glaucoma suspects.
Schulzer M; Drance SM; Douglas GR
Ophthalmology; 1991 Mar; 98(3):301-7. PubMed ID: 2023749
[TBL] [Abstract][Full Text] [Related]
18. Lack of long-term drift in timolol's effectiveness in patients with ocular hypertension.
Bengtsson B; Heijl A
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2839-42. PubMed ID: 11687526
[TBL] [Abstract][Full Text] [Related]
19. Enhanced acute ocular hypotensive response to timolol with dexamethasone treatment.
Rom M; Schwartz B; Bealka N
J Glaucoma; 1997 Apr; 6(2):111-6. PubMed ID: 9098819
[TBL] [Abstract][Full Text] [Related]
20. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
